Based on Tumor and Immune System Interaction Database, Huang et al. reported a positive correlation of VISTA and almost all critical immunomodulators (among them PD-1/PD-L1) in various cancers including RCC (Huang et al. 2020). This evidence concerns the gene CD274 and cancer.